Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
vatalanib epidermal growth factor receptor NA Successful target TTD , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.03 phase 2 unknown
vatalanib vegfr1 messenger rna NA Successful target TTD , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.4 phase 2 inhibitor
vatalanib vascular endothelial growth factor receptor 1 small molecule NA drugbank , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.4 investigational unknown
vatalanib vegfr1 messenger rna NA Successful target TTD , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.4 phase 2 unknown
vatalanib vascular endothelial growth factor receptor 1 small molecule NA drugbank , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.4 investigational inhibitor
vatalanib vascular endothelial growth factor receptor 3 small molecule Successful target TTD , drugbank , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.39 investigational,phase 2 unknown
vatalanib vascular endothelial growth factor receptor 3 small molecule Successful target TTD , drugbank , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.39 investigational,phase 2 inhibitor
vatalanib vascular endothelial growth factor receptor 2 small molecule Successful target TTD , drugbank , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.29 investigational,phase 2 unknown
vatalanib vascular endothelial growth factor receptor 2 small molecule Successful target TTD , drugbank , DGIDB Second Primary Cancers[MeSHID:D016609]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.29 investigational,phase 2 inhibitor
click here to return to the previous page